Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
As GLP-1 receptor agonists become a cornerstone of diabetes care, clinicians are rethinking how often patients on GLP-1 therapy need follow-up visits. These therapies often deliver improved glycemic control, weight loss, and cardiovascular benefits. However, does this stability mean fewer clinic visits, or does it require closer monitoring in new …
Read More »GLP-1 Therapy and Visit Frequency: Do Patients Need Less Follow-Up—or More?
